BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6155033)

  • 21. The diverse effects of topical and systemic administration of zinc on the virulence of herpes simplex genitalis.
    Tennican PO; Carl GZ; Chvapil M
    Life Sci; 1979 May; 24(20):1877-83. PubMed ID: 222985
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical zinc in the treatment of mice infected intravaginally with herpes genitalis virus.
    Tennican P; Carl G; Frey J; Thies C; Chvapil M
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):593-7. PubMed ID: 7413679
    [No Abstract]   [Full Text] [Related]  

  • 24. [Letter: New treatment methods in recurrent herpes simplex].
    Egeland T
    Tidsskr Nor Laegeforen; 1976 Apr; 96(12):728. PubMed ID: 936139
    [No Abstract]   [Full Text] [Related]  

  • 25. [Possibilities and limits of chemotherapy of diseases caused by herpes simplex and varicella-zoster virus].
    Wassilew SW
    Hautarzt; 1983 Jan; 34(1):1-5. PubMed ID: 6841073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How I treat herpes simplex.
    Glogau RG
    Med Times; 1980 Mar; 108(3):66-8. PubMed ID: 7366363
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the therapeutic effect of Wratizolin in selected dermatoses.
    Michałowski R; Olejnicka Z; Kozak S; Urban J
    Arch Immunol Ther Exp (Warsz); 1983; 31(5):649-54. PubMed ID: 6675572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tromantadine hydrochloride in the treatment of herpes simplex. Results of a double-blind therapeutic trial and an open prophylactic investigation.
    Hellgren L; Hermann LS
    Dermatologica; 1983; 167(5):267-72. PubMed ID: 6360739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of Wratizolin treatment of selected skin diseases with particular reference to those of viral etiology.
    Wasik F; Gasior-Chrzan B; Woytoń A; Cisło M; Dabrowska-Widera J
    Arch Immunol Ther Exp (Warsz); 1983; 31(5):645-8. PubMed ID: 6675571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flumethasone pivalate (Locorten) and other topical steroids.
    Med Lett Drugs Ther; 1971 Apr; 13(9):33-5. PubMed ID: 5558447
    [No Abstract]   [Full Text] [Related]  

  • 31. [Possibilities in the use of interferon inducer substance in the treatment of viral dermatoses].
    Buchvald J; Borecky L; Doskocil J
    Z Hautkr; 1975 Nov; 50(21):909-11. PubMed ID: 1108471
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent therapeutic advances for common cutaneous problems.
    Zuehlke RL
    Am Fam Physician; 1974 Jun; 9(6):70-4. PubMed ID: 4275327
    [No Abstract]   [Full Text] [Related]  

  • 33. Topical phosphonoacetic acid treatment of cutaneous herpes simplex infections in the guinea pig.
    McCarty JR; Jarratt MT
    J Am Acad Dermatol; 1979 Sep; 1(3):244-8. PubMed ID: 512074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of herpes simplex of the lid margin with vidarabin ointment (author's transl)].
    Egerer I
    Wien Klin Wochenschr; 1979 Mar; 91(5):168-9. PubMed ID: 425538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interferon inducer in the treatment of viral dermatoses].
    Bukhvald I; Boretski L
    Vestn Dermatol Venerol; 1981 Mar; (3):69-70. PubMed ID: 7020278
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical zinc sulphate solution for treatment of viral warts.
    Sharquie KE; Khorsheed AA; Al-Nuaimy AA
    Saudi Med J; 2007 Sep; 28(9):1418-21. PubMed ID: 17768472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of acyclovir gel in herpes simplex: clinical implications.
    Seth AK; Misra A; Umrigar D; Vora N
    Med Sci Monit; 2003 Jul; 9(7):PI93-8. PubMed ID: 12883465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of bacteriophage nucleic acid inducers of interferon in man.
    Borecký L
    Tex Rep Biol Med; 1977; 35():535-40. PubMed ID: 358474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cure for recurrent herpes simplex.
    Willis WF
    Arch Dermatol; 1978 Jul; 114(7):1096. PubMed ID: 686738
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of complement inhibition in topical therapy of muco-cutaneous herpes simplex virus infections.
    Gancevici GG
    Roum Arch Microbiol Immunol; 1993; 52(4):293-303. PubMed ID: 7827366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.